Lausanne, Switzerland

Alexandre Harari

This inventor holds 5 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent. Top assignees: Arizona State University, Consejo Superior De Investigaciones Cientificas, Ippox Foundation. Active years: 2015-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alexandre Harari. Retrieved from https://idiyas.com/inventor/alexandre-harari

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 5 

% Patents Active = 80.0

 

Average Co-Inventor Count = 7.2

ph-index = 2

Forward Citations = 24(Granted Patents)


Company Filing History:


Years Active: 2015-2025

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Alexandre Harari

Introduction

Alexandre Harari is a notable inventor based in Lausanne, Switzerland. He has made significant contributions to the field of immunology, holding a total of five patents. His work focuses on the development of modified immunization vectors, which have the potential to enhance vaccine efficacy.

Latest Patents

Among his latest patents, Harari has developed modified immunization vectors. The disclosure relates to recombinant vectors and methods for using the same. In certain embodiments, the recombinant vectors are immunogenic, showcasing his innovative approach to vaccine development.

Career Highlights

Throughout his career, Harari has worked with esteemed organizations such as the Consejo Superior de Investigaciones Científicas and Ippox Foundation. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

Harari has collaborated with prominent figures in the field, including Giuseppe Pantaleo and Thierry Calandra. These partnerships have further enriched his research and innovation efforts.

Conclusion

Alexandre Harari's work in developing modified immunization vectors highlights his commitment to advancing immunological research. His contributions are paving the way for future innovations in vaccine technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…